⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1058149 | 0.75 | TSHR (0.43) | — | |
| SCHEMBL21224483 | 0.67 | HRH3 (0.41) | — | |
| SCHEMBL3279296 | 0.67 | CA1 (0.39) | — | |
| SCHEMBL2729745 | 0.67 | HRH3 (0.41) | — | |
| SCHEMBL5358 | 0.67 | HRH3 (0.41) | — | |
| SCHEMBL315447 | 0.67 | — | — | |
| SCHEMBL8910049 | 0.64 | — | — | |
| SCHEMBL14270553 | 0.64 | HRH3 (0.39) | — | |
| Hydrochloric Acid SCHEMBL210163 | 0.64 | HRH3 (0.39) | — | |
| Iodide SCHEMBL1758226 | 0.64 | HRH3 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110317197-A | A kind of aminomethyl substituted silibinin derivative and its preparation method and application | 天士力医药集团股份有限公司 | 2019-10-11 | — | — | CN | claimed |
| US-20070078146-A1 | Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma | PHARMACIA CORPORATION | 2007-04-05 | — | — | US | claimed |
| US-20060049052-A1 | Ampholytic buffer having high buffering capacity and high conductivity in isoelectric form | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2006-03-09 | — | — | US | claimed |
| EP-1144403-A1 | SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS | G.D. SEARLE & CO. (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2000031063-A1 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS | G.D. SEARLE & CO. (US) | 2000-06-02 | — | — | WO | claimed |
| US-4650868-A | 7-deazapurine derivatives useful as antitumor agents | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-03-17 | — | — | US | claimed |
| EP-3884019-A1 | HOME CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2021-09-29 | — | — | EP | disclosed |
| CN-113227340-A | Home care compositions | 高露洁-棕榄公司 | 2021-08-06 | — | — | CN | disclosed |
| US-11008533-B2 | Home care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2021-05-18 | — | — | US | disclosed |
| WO-2020139335-A1 | HOME CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2020-07-02 | — | — | WO | disclosed |
| US-20200208081-A1 | HOME CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2020-07-02 | — | — | US | disclosed |
| US-7071198-B1 | Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma | PHARMACIA CORPORATION (US) | 2006-07-04 | — | — | US | disclosed |
| EP-1500657-A1 | Substituted pyrazoles as P38 kinase inhibitors | G.D. Searle LLC (US) | 2005-01-26 | — | — | EP | disclosed |
| EP-1144403-A1 | SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS | G.D. SEARLE & CO. (US) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000031063-A1 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS | G.D. SEARLE & CO. (US) | 2000-06-02 | — | — | WO | disclosed |
| US-4650868-A | 7-deazapurine derivatives useful as antitumor agents | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-03-17 | — | — | US | disclosed |
| EP-0160910-A2 | 7-Deazapurine derivatives and their production | Takeda Chemical Industries, Ltd. (JP) | 1985-11-13 | — | — | EP | disclosed |
| EP-0032058-B1 | THIAZOLE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-10-26 | — | — | EP | disclosed |
| US-4411900-A | ANTIALLERGENS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-10-25 | — | — | US | disclosed |
| EP-0032058-A1 | Thiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-07-15 | — | — | EP | disclosed |